Related Experiment Video
Updated: May 13, 2026

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
Published on: October 25, 2024
Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis
Zhenping Li1, Yan Yue, Sidong Xiong
1Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, P.R. China.
Insights
Male mice exhibit higher Th17 cell responses to coxsackievirus B3 (CVB3) infection, leading to increased viral myocarditis severity. Estrogen inhibits Th17 differentiation, explaining this observed sex difference in disease susceptibility.
Area of Science:
- Immunology
- Virology
- Endocrinology
Background:
- Viral myocarditis, often caused by coxsackievirus B3 (CVB3), disproportionately affects males.
- The underlying mechanisms for this sex bias remain unclear.
- T helper 17 (Th17) cells are implicated in CVB3-induced myocarditis, but their role in the gender disparity is unknown.
Purpose of the Study:
- To investigate the role of Th17 cells in the sex difference observed in CVB3-induced viral myocarditis.
- To determine the impact of sex hormones on Th17 cell differentiation following CVB3 infection.
Main Methods:
- Comparison of splenic Th17 cell frequency and associated cytokine/transcriptional factor expression in male and female mice post-CVB3 infection.
- Evaluation of sex hormone effects on Th17 cell differentiation in vitro and in vivo.
- Assessment of myocarditis severity following interleukin-17 neutralization.
Main Results:
- Male mice showed significantly higher Th17 cell frequencies and associated molecular markers after CVB3 infection compared to females.
- Neutralization of interleukin-17 abolished the male predominance of myocarditis.
- Estradiol inhibited Th17 differentiation, while testosterone had no significant effect.
Conclusions:
- Th17 cells are predominantly induced in male mice infected with CVB3, contributing to the observed sex difference in myocarditis susceptibility.
- Estrogen's inhibitory effect on Th17 differentiation is a key factor in this gender bias.
- Findings offer insights into Th17 cell roles in viral myocarditis and potential therapeutic targets.
Background:
Viral myocarditis is often caused by coxsackievirus B3 (CVB3) infection and occurs more frequently in males. So far, the mechanisms for this sex difference are not fully elucidated. As a new proinflammatory T cell population, Th17 cells are required for the development of CVB3-induced myocarditis, but their impact on the gender bias in viral myocarditis is still unknown.
Methods:
Male and female mice were intraperitoneally infected with CVB3; 7 days later, the frequency of splenic Th17 cells and the expression of associated cytokines and transcriptional factors were compared. Meanwhile, the impact of sex hormones on Th17 cell differentiation post CVB3 infection was also evaluated.
Results:
In infected male mice, Th17 cell frequency was remarkably increased and significantly higher than that in female mice. Accordingly, the expression of associated cytokines and transcriptional factors was also obviously augmented in males. When neutralizing interleukin-17 by monoclonal antibody, the male prevalence of myocarditis was obviously abolished, further confirming the effect of Th17 cells on gender bias in viral myocarditis. It was also found that estradiol significantly inhibited the Th17 differentiation post CVB3 infection both in vitro and in vivo. However, testosterone showed no such effects.
Conclusions:
Th17 cells were predominantly induced in CVB3-infected males than females as the inhibitory effect of estrogen on Th17 differentiation and played an important role in the sex differences in the sensitivity to CVB3-induced myocarditis. This study may help us understand the role of Th17 cells in viral myocarditis and facilitate the development of corresponding therapeutic strategies.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy

